What does a modern Clomiphene Citrate PCT protocol actually look like in practice?

A modern Clomiphene Citrate protocol is structured in declining phases rather than a flat dose. A common framework uses 50 mg twice daily for days 1–7 (loading phase), 50 mg once daily for days 8–21 (maintenance phase), and 25 mg daily for days 22–28 (taper). The start date is calculated from the clearance time of the preceding compound, not arbitrarily. Blood work at baseline, mid-protocol, and conclusion guides any adjustments.

How does a modern PCT approach differ from the traditional fixed-dose method?

Traditional PCT applied a uniform daily dose for a set period with no reference to suppression depth or compound half-life. Modern approaches treat both as required inputs: suppression severity determines the opening dose intensity, and compound clearance time determines when the protocol begins. The result is a personalised, phase-based schedule that steps down as the HPG axis reasserts itself, reducing the risk of both under-treatment and prolonged unnecessary SERM exposure.

What role does a SERM like Clomiphene Citrate play in contemporary PCT design?

In contemporary protocol design, SERMs like Clomiphene Citrate serve as the primary pharmacological lever for gonadotropin restoration. By occupying hypothalamic oestrogen receptors, Clomiphene Citrate removes the feedback inhibition on GnRH pulsatility, prompting the pituitary to release LH and FSH and the testes to resume testosterone synthesis. Modern designers position SERMs within a broader framework that may include aromatase inhibitors or hCG during the anabolic cycle, leaving Clomiphene Citrate to consolidate recovery in the post-cycle window.

Can a single 50 mg tablet be split to achieve a 25 mg taper dose?

Yes. Each Beligas Clomid tablet contains 50 mg of Clomiphene Citrate and can be split to deliver an approximate 25 mg dose for the tapering phase of a modern protocol. Tablet splitting is a practical convenience supported by the 50 mg/tab concentration — it means one pack of 50 tablets covers all phases of a standard four-week structured protocol without requiring a separate lower-strength product.

Why is the 50 mg per tablet concentration considered the most versatile option for structured PCT?

The 50 mg concentration is the highest single-tablet strength available in this compound category and offers the greatest dosing flexibility across protocol phases. Full tablets serve the loading and maintenance phases directly; halved tablets provide the taper dose; and the tablet count per pack (50 units) aligns with the total tablet requirement of a standard 28-day declining-step protocol. This eliminates the need to source multiple pack sizes or strengths for a single course. (2) angle_used

HPLC Verified

Beligas Pharmaceuticals

Clomid 50mg/tab 50 Tabletten by Beligas Pharmaceuticals

Name: Clomid 50mg/tab 50 Tablets by Beligas Pharmaceuticals
Brand: Beligas Pharmaceuticals
SKU: PCT-CLOM-BEL-002
Price: 36.00 EUR
Availability: InStock

Beligas Pharmaceuticals Clomid provides 50 mg of Clomiphene Citrate per tablet — an HPLC-verified SERM formulated to support controlled gonadotropin restoration and systematic testicular recovery within a structured post-cycle framework. The 50-tablet pack accommodates all phases of a declining-step recovery course, from the opening induction dose through the final taper, without requiring additional pack sizes. Every production lot is released only after chromatographic potency confirmation against pharmacopoeial reference standards, ensuring the declared 50 mg content is analytically validated rather than label-estimated.

€36.00Free shipping on orders over €300

In stock

Ships within 48 h Lab-tested batch

Delivers a chromatographically confirmed 50 mg Clomiphene Citrate dose per tablet — no estimated label claims
Accommodates all three phases of a modern declining-step protocol within a single 50-tab pack
Tablet format allows clean splitting for 25 mg taper doses without additional product
Manufactured under GMP-compliant conditions with lot-by-lot analytical release criteria
Supports data-anchored recovery when paired with baseline and mid-protocol bloodwork
Fifty-tablet pack quantity aligns precisely with a standard 28-day structured PCT course
LAL endotoxin testing applied within the manufacturing environment ensures batch-level safety documentation

Phase	Duration	Dosage	Note
Loading	Days 1–7	50 mg twice daily (100 mg/day)	Begin only after the preceding compound has cleared based on its half-life; this phase establishes receptor blockade quickly
Maintenance	Days 8–21	50 mg once daily	HPG axis reassertion is monitored; bloodwork at day 14 informs whether duration should be extended
Taper	Days 22–28	25 mg once daily (half tablet)	Gradual step-down reduces rebound risk; mid-protocol bloodwork guides the decision to conclude or continue

Key takeaways

Structure your PCT in declining phases, not flat daily doses.
Confirm compound clearance time before starting Clomiphene Citrate.
Use bloodwork data to extend or taper the protocol — not just a calendar.
Split 50 mg tablets to achieve precise 25 mg taper doses.
Trust HPLC-verified tablet content for accurate phase-by-phase dosing.

What Clomiphene Citrate Does Inside a Modern PCT Framework

Clomiphene Citrate is a selective oestrogen receptor modulator (SERM) that restores endogenous testosterone production by occupying oestrogen receptors in the hypothalamus, thereby removing the negative-feedback signal that suppresses pulsatile GnRH release. Modern PCT protocols treat this mechanism not as a blunt recovery trigger but as a precision tool: the drug is dosed, timed, and tapered according to the half-life of the preceding anabolic agent and the individual's baseline hormonal status. Compared to legacy flat-dose approaches — where a single fixed amount was taken daily without adjustment — current evidence-informed protocols employ a declining-step structure that mirrors the natural reassertion of HPG axis activity.

Beligas Pharmaceuticals Clomid delivers exactly 50 mg of Clomiphene Citrate per tablet, a concentration confirmed by HPLC (High-Performance Liquid Chromatography) on a batch-by-batch basis. Clomiphene Citrate occupies hypothalamic oestrogen receptors and thereby amplifies LH and FSH secretion. Elevated LH stimulates Leydig cells to resume testosterone synthesis. This sequence — receptor blockade → gonadotropin release → intratesticular testosterone production — is the pharmacological backbone around which modern protocol designers build their timing models.

How Modern PCT Protocols Differ Structurally From Traditional Approaches

Traditional PCT applied a single static dose for a fixed number of weeks regardless of compound half-life or suppression depth. Modern protocol design treats those two variables — suppression severity and clearance time — as primary inputs. A typical structured approach opens with a higher loading phase (often 50 mg twice daily for the first week), then steps down to a maintenance phase (50 mg once daily), and concludes with a taper (25 mg daily, achievable by splitting a 50 mg tablet). The 50 mg per tablet concentration of Beligas Clomid accommodates all three phases within a single SKU, eliminating the need for multiple pack sizes.

Blood work anchors every responsible modern protocol: baseline LH, FSH, and total testosterone are measured before the first tablet, then rechecked at the midpoint and conclusion. These values, not a calendar date, determine whether the protocol is extended, tapered earlier, or supplemented. This data-driven approach represents the clearest structural departure from historical flat-dose practice.

Manufacturing Integrity: HPLC Verification and GMP Conditions

Accurate dosing cannot be assumed from label claims alone; it must be demonstrated analytically. Beligas Pharmaceuticals subjects each production lot of Clomid 50mg to HPLC quantification, cross-referencing the measured Clomiphene Citrate peak against certified pharmacopoeial reference standards before any release decision is made. LAL endotoxin testing supports sterility assurance across the manufacturing environment. GMP-compliant production conditions govern tablet compression, excipient selection, and batch documentation — providing a traceable quality chain from raw material intake to finished tablet.

For a compound whose dosing precision directly governs the speed and completeness of hormonal recovery, this level of analytical control is not optional; it is operationally necessary.

Usage

Calculate the clearance time of your preceding anabolic compound using its known half-life before scheduling your first tablet — do not begin the protocol while suppressive agents are still biologically active.
Establish baseline bloodwork (LH, FSH, total testosterone, oestradiol) before day 1 so that mid-protocol and end-of-protocol values can be meaningfully compared.
Begin the loading phase at 50 mg twice daily with food to minimise gastric discomfort; space doses approximately 12 hours apart to maintain consistent plasma levels.
At the transition to the maintenance phase (day 8), reduce to one 50 mg tablet daily, taken at the same time each day to support compliance within a structured routine.
Obtain a mid-protocol blood panel at approximately day 14; if LH, FSH, and testosterone are trending toward reference ranges, proceed to the taper; if values remain suppressed, extend the maintenance phase before stepping down.
Complete the taper phase using a split tablet (25 mg daily); do not discontinue abruptly from the maintenance dose, as a stepped conclusion reduces the likelihood of oestrogen-rebound effects once the SERM is withdrawn.

Warnings

Contraindications: Clomiphene Citrate is contraindicated in individuals with known hypersensitivity to the compound, pre-existing hepatic impairment, or documented ovarian cysts unrelated to polycystic ovary syndrome. Use is not appropriate during pregnancy. Individuals with a history of visual disturbances or thromboembolic conditions should avoid use without specialist medical clearance.

Side Effects: Reported adverse effects include visual blurring or scotomata (which necessitate immediate discontinuation), mood disturbances including irritability and low mood, hot flushes, and — in some cases — elevated oestradiol resulting from increased aromatisation of rising endogenous testosterone. Prolonged high-dose use has been associated with reduced semen quality in a minority of users.

Monitoring: Periodic liver enzyme assessment is recommended for protocols extending beyond four weeks. Oestradiol and testosterone should be measured at baseline, mid-protocol, and conclusion. If visual symptoms of any kind emerge, discontinue immediately and seek ophthalmological assessment. Blood pressure should be monitored throughout, as gonadotropin-driven testosterone rises can influence cardiovascular parameters.

PCT: Clomiphene Citrate is intended for short-term structured use within a defined recovery protocol. It is not a long-term hormonal maintenance agent. Protocol duration and dosing decisions should reference baseline bloodwork, not default to a fixed calendar schedule. Concurrent aromatase inhibitor use should be titrated conservatively to avoid over-suppression of oestradiol, which is itself required for normal HPG axis function.

Frequently asked questions

What does a modern Clomiphene Citrate PCT protocol actually look like in practice?: A modern Clomiphene Citrate protocol is structured in declining phases rather than a flat dose. A common framework uses 50 mg twice daily for days 1–7 (loading phase), 50 mg once daily for days 8–21 (maintenance phase), and 25 mg daily for days 22–28 (taper). The start date is calculated from the clearance time of the preceding compound, not arbitrarily. Blood work at baseline, mid-protocol, and conclusion guides any adjustments.
How does a modern PCT approach differ from the traditional fixed-dose method?: Traditional PCT applied a uniform daily dose for a set period with no reference to suppression depth or compound half-life. Modern approaches treat both as required inputs: suppression severity determines the opening dose intensity, and compound clearance time determines when the protocol begins. The result is a personalised, phase-based schedule that steps down as the HPG axis reasserts itself, reducing the risk of both under-treatment and prolonged unnecessary SERM exposure.
What role does a SERM like Clomiphene Citrate play in contemporary PCT design?: In contemporary protocol design, SERMs like Clomiphene Citrate serve as the primary pharmacological lever for gonadotropin restoration. By occupying hypothalamic oestrogen receptors, Clomiphene Citrate removes the feedback inhibition on GnRH pulsatility, prompting the pituitary to release LH and FSH and the testes to resume testosterone synthesis. Modern designers position SERMs within a broader framework that may include aromatase inhibitors or hCG during the anabolic cycle, leaving Clomiphene Citrate to consolidate recovery in the post-cycle window.
Can a single 50 mg tablet be split to achieve a 25 mg taper dose?: Yes. Each Beligas Clomid tablet contains 50 mg of Clomiphene Citrate and can be split to deliver an approximate 25 mg dose for the tapering phase of a modern protocol. Tablet splitting is a practical convenience supported by the 50 mg/tab concentration — it means one pack of 50 tablets covers all phases of a standard four-week structured protocol without requiring a separate lower-strength product.
Why is the 50 mg per tablet concentration considered the most versatile option for structured PCT?: The 50 mg concentration is the highest single-tablet strength available in this compound category and offers the greatest dosing flexibility across protocol phases. Full tablets serve the loading and maintenance phases directly; halved tablets provide the taper dose; and the tablet count per pack (50 units) aligns with the total tablet requirement of a standard 28-day declining-step protocol. This eliminates the need to source multiple pack sizes or strengths for a single course. (2) angle_used

Manufacturer

At Beligas Pharmaceuticals, the analytical release framework for Clomid 50mg is organised around a single non-negotiable criterion: the Clomiphene Citrate content per tablet must be returned as a measured, chromatographically confirmed value before a batch is assigned a release status. That measurement is produced via HPLC — High-Performance Liquid Chromatography — a technique that separates the active molecule from tablet excipients and process-related matrix components, then quantifies it against certified pharmacopoeial reference standards on a lot-specific basis. The figure printed on the label is therefore the figure validated in the laboratory, not a calculated approximation from input-weight records. This distinction carries particular weight for a SERM used in phase-structured PCT protocols, where dosing accuracy in the first week directly shapes the trajectory of gonadotropin recovery across the subsequent four. Beyond active-content verification, Beligas applies LAL endotoxin testing within its manufacturing environment and operates under GMP-compliant production conditions that govern everything from raw material receipt to finished-tablet release documentation.

Product details

Brand	Beligas Pharmaceuticals
Active ingredient	clomiphene citrate
Also known as	Clomiphene, Clomid, Clomiphen, Beligas Pharmaceuticals Clomiphene
Strength	50 mg
Form	Tabletten
Pack size	50 pieces
Item number	PCT-CLOM-BEL-002

Reviews

No reviews yet. Be the first to review this product.

Write a review

Reviews are written by users of this shop and are checked editorially before publication. Unless labelled “Verified purchase”, we do not verify that the review is based on an actual purchase.

Similar products

Clomiphene Citrate 50mg/tab 24 Tablets by Anfarm Hellas

Lab Tested

Clomiphene Citrate 50mg/tab 24 Tabletten by Anfarm Hellas

Anfarm Hellas Clomiphene Citrate 50mg/tab is a pharmaceutical-grade SERM in individually blister-sealed tablets, engineered to reactivate the hypothalamic-pituitary-gonadal axis after anabolic suppression. The 24-tablet pack is sized to cover a complete induction phase at 50mg daily or an extended taper at half-dose, giving the user measurable flexibility across different suppression depths. Independent HPLC potency verification and LAL endotoxin screening are applied at the finished-tablet stage before any lot is released for distribution.

€12.00

CloTrex 50mg/tab 100 Tablets by Concentrex Labs

Pharma Grade

CloTrex 50mg/tab 100 Tabletten by Concentrex Labs

CloTrex by Concentrex Labs is a pharma-grade Clomiphene Citrate tablet formulated at 50 mg per unit and designed specifically for the shorter, leaner PCT demands that follow a mild anabolic cycle — where suppression depth is low and recovery windows are meaningfully shorter than those required after heavy compound use. Each 100-tablet jar provides enough supply to run a full mini-PCT without needing to split or reorder mid-protocol. Quality is locked in at the finished-tablet stage: HPLC potency verification against a certified pharmacopoeial reference standard is completed per lot, with LAL endotoxin screening applied under Concentrex Labs' GMP-compliant production framework.

€45.00

Clomiphene Tablets 50mg/tab 50 Tablets by Genesis

Purity Tested

Clomiphene Tablets 50mg/tab 50 Tabletten by Genesis

Genesis Clomiphene Tablets deliver 50 mg of pharmaceutical-grade clomiphene citrate per tablet across a 50-tablet pack, purpose-built for structured post-cycle therapy following moderate anabolic suppression. Where a moderate cycle — involving compounds with meaningful half-lives or stacked moderate doses — produces a deeper hypothalamic-pituitary shutdown than a minimal run, a four- to six-week Clomiphene protocol at graded doses provides the stimulatory pressure needed to reactivate endogenous testosterone production at speed. Quality assurance is embedded at the batch level: every production lot is released only after HPLC potency verification and LAL endotoxin screening confirm compliance with declared specification.

€24.00

Batch Tested

Clomiphene Citrate 50mg/tab 50 Tablets by Hilma Biocare

Hilma Biocare Clomiphene Citrate 50mg/tab is a pharmaceutical-grade SERM engineered for aggressive HPTA reinstatement following prolonged or heavily suppressive anabolic-androgenic steroid cycles, where near-zero gonadotropin output demands a front-loaded, phase-structured recovery approach. Each 50-tablet pack at 50 mg per unit provides the dosing headroom required for a high-load opening phase and a systematic taper through week six, without requiring a second purchase. Independent HPLC potency quantification and LAL endotoxin screening are completed at the finished-tablet stage, with GMP-certified batch documentation attached to every lot prior to release.

€34.00

Stack it with

Pairs well with these products.

High Concentration

Quant-Equipoise 300mg/ml 10ml Vial by Beligas Pharmaceuticals

Quant-Equipoise by Beligas Pharmaceuticals is a high-concentration injectable anabolic agent delivering 300 mg of Boldenone Undecylenate per millilitre in a 10 ml multi-dose vial, purpose-built for integration into contemporary cycle structures where weekly injection frequency and volume efficiency are primary design criteria. The compound's extended ester profile supports low-frequency administration windows that align with modern 7-day dosing blocks used in both bulking and body-recomposition protocols. Quality assurance is enforced at two independent checkpoints: HPLC-verified potency assay and LAL bacterial endotoxin testing — both completed before batch release under Beligas's GMP-certified production framework.

€47.00

Bolden-250 250mg/ml 10x1ml Ampoules by BM Pharmaceuticals

Long-Acting Formula

Bolden-250 250mg/ml 10x1ml Ampullen by BM Pharmaceuticals

Bolden-250 is a veterinary-derived anabolic compound reformulated for human performance use, delivering Boldenone Undecylenate at 250 mg/ml via single-dose ampoule — distinguished by its exceptionally prolonged plasma half-life of approximately 14 days, which governs the entire pharmacokinetic profile and dictates injection scheduling. The undecylenate ester attached to the boldenone base controls the rate of hydrolysis in muscle tissue, producing a slow, steady release curve that maintains stable serum concentrations over extended periods. Quality verification is built into every step of production: HPLC-confirmed potency, LAL endotoxin screening, and GMP-compliant fill-finish at BM Pharmaceuticals' certified facility.

€48.00

Brand Quality

EquiTrex 350mg/ml 10ml Vial by Concentrex Labs

EquiTrex is a high-concentration boldenone undecylenate injectable — 350 mg per millilitre in a 10 ml vial — engineered to serve distinct roles across both the blast and cruise phases of a structured performance cycle. Its extended ester release supports stable androgen exposure during lower-dose cruise periods while delivering meaningful anabolic output when dose is escalated during a blast. Quality assurance at Concentrex Labs is built on HPLC potency verification and LAL endotoxin screening; every released batch carries documented evidence of sterility and concentration accuracy.

€52.00

Pro Choice

EQ 300 300mg/ml 10ml Vial by Dragon-Pharma

Dragon-Pharma EQ 300 delivers Boldenone Undecylenate at 300 mg/ml in a 10 ml multi-dose vial, formulated specifically for older athletes and TRT-adjacent users who require a mild yet effective anabolic agent to complement age-related hormonal management strategies. Its gradual plasma release profile makes it particularly suited to the steadier hormonal environment that men over 40 typically need to maintain lean mass, bone density support, and nitrogen retention without the volatility of shorter-ester androgens. Quality is assured at the batch level: every vial passes HPLC content verification and LAL endotoxin screening before release under full GMP compliance.

€44.00